Showing results (111-120 of 1,275) with videos related to

Sort By:
Pageof 128
PET Clinics|May 10, 2016
Exploring Tumor Biology with Fluorodeoxyglucose-Positron Emission Tomography Imaging in Breast CarcinomaSandip Basu, Rakesh Kumar, Ayşe Mavi, et al.
PET Clinics|May 10, 2016
Positron Emission Tomography and Thyroid CancerMuammer Urhan, Ayse Mavi, Abass Alavi, et al.
PET Clinics|June 18, 2022
Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing MisconceptionsNadia Withofs, Rakesh Kumar, Abass Alavi, et al.
Radiologic Clinics of North America|February 8, 2005
Fluorodeoxyglucose-PET in the management of malignant melanomaRakesh Kumar, Ayse Mavi, Gonca Bural, et al.
Molecular Imaging and Biology|December 17, 2010
Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disordersSandip Basu, Babak Saboury, Tom Werner, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2011
PET and PET/CT in the management of thyroid cancerSandip Basu, Muammer Urhan, Joshua Rosenbaum, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 17, 2007
Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodulesKhaled Alkhawaldeh, Gonca Bural, Rakesh Kumar, et al.
Nuclear Medicine Communications|February 6, 2009
Impact of fluorodeoxyglucose PET on the management of esophageal cancerAli Salavati, Sandip Basu, Pedram Heidari, et al.
Journal of Thoracic Imaging|December 20, 2012
Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantificationThomas C Kwee, Drew A Torigian, Abass Alavi
Nuclear Medicine Communications|April 9, 2016
Atherosclerotic 18F-FDG and MDP uptake in femoral arteries, changes with ageGonca G Bural, Drew Torigian, Domenico Rubello, et al.
Pageof 128